TrialHypertension research : official journal of the Japanese Society of Hypertension2023

Results from a phase 1, randomized, double-blind, multiple ascending dose study characterizing the pharmacokinetics and demonstrating the safety and selectivity of the aldosterone synthase inhibitor baxdrostat in healthy volunteers.

Mason W Freeman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.